National Kidney Foundation Pushes Genetic Testing into Mainstream Kidney Care
Event summary
- National Kidney Foundation held its Genetics in Kidney Health Summit on September 18-19, 2026, in Dallas, TX.
- Summit aimed to accelerate responsible use of genetic testing in kidney care, with 200+ nephrologists, genetic counselors, researchers, and patients in attendance.
- Participants focused on integrating genetic testing into routine care, including practical strategies for ordering tests, interpreting results, and coordinating follow-up care.
- Patient advocates emphasized the need for equitable access to genetic testing and whole-person care approaches.
- NKF will use summit insights to support continued education and practical implementation of genetic testing across kidney care settings.
The big picture
The summit reflects a broader industry shift toward precision medicine in nephrology, as genetic testing moves from specialized centers to community practice. With 1 in 7 U.S. adults affected by chronic kidney disease and significant disparities in diagnosis and treatment, the integration of genetic testing could improve diagnostic accuracy and guide more personalized treatment approaches. The National Kidney Foundation's efforts to standardize practices and expand access may position genetic testing as a mainstream tool in kidney care within the next 3-5 years.
What we're watching
- Adoption Pace
- How quickly community nephrologists will integrate genetic testing into routine practice, given the need for new workflows and coordination with genetic specialists.
- Equity Challenges
- Whether the field can overcome barriers to equitable access, including geographic, economic, and cultural differences in healthcare access.
- Data Utilization
- The pace at which clinical data systems will be developed to support research, variant reclassification, and clinical trial readiness.
Related topics
